Lupin Limited has informed the Exchange regarding a press release dated March 21, 2023, titled "Lupin Receives Approval from US FDA for Brexpiprazole Tablets.".
Lupin Limited has informed the Exchange regarding a press release dated March 21, 2023, titled "Lupin Receives Approval from US FDA for Brexpiprazole Tablets.".